Roche

San Diego-based Forge Therapeutics struck an agreement with Roche centering on Forge’s antibiotic for treatment-resistant infections.

Before Rosina Gil became one of the top dancers in the world, she was the target of bullying. That’s why she’s proud, now, to be part of a group of people that are celebrated for their differences.

Every month, a car would pick up Jeff Borghoff at his home in Forked River, New Jersey, and drive him to the Advanced Memory Research Institute of New Jersey. There, doctors would help him settle into a comfortable chair and hook him up to an IV. For the next 40 minutes to an hour, an experimental treatment aimed at slowing...

Workers at a Massachusetts supermarket have found a rare orange lobster.

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests. It’s good news, but it comes nearly two decades after the drug first went on the...

U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder. The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE’-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.